ImmunityBio (IBRX) Shareholder's Equity Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.21% |
| Dec 31, 2025 | -33.39% |
| Sep 30, 2025 | -59.27% |
| Jun 30, 2025 | -110.80% |
| Mar 31, 2025 | -95.46% |
| Dec 31, 2024 | -99.87% |
| Sep 30, 2024 | -49.52% |
| Jun 30, 2024 | -45.90% |
| Mar 31, 2024 | -43.65% |
| Dec 31, 2023 | -55.70% |
| Sep 30, 2023 | -35.30% |
| Jun 30, 2023 | -40.89% |
| Mar 31, 2023 | -36.01% |
| Dec 31, 2022 | -32.31% |
| Sep 30, 2022 | -30.64% |
| Jun 30, 2022 | -29.69% |
| Mar 31, 2022 | -26.29% |
| Dec 31, 2021 | -23.14% |
| Sep 30, 2021 | -21.16% |
| Jun 30, 2021 | -19.96% |
| Mar 31, 2021 | -20.48% |
| Dec 31, 2020 | -18.46% |
| Sep 30, 2020 | -16.45% |
| Jun 30, 2020 | -35.27% |
| Dec 31, 2019 | -22.28% |
| Dec 31, 2018 | 88.54% |